Clinical Trials Directory

Trials / Completed

CompletedNCT01858987

Stapler vs. LigaSure in Elective Hepatic Resection

Stapler vs. LigaSure for Transection of the Parenchyma in Elective Hepatic Resection: CRUNSH II - A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
138 (actual)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The optimal technique of parenchymal transection in liver surgery has remained a matter of controversial debate among hepatobiliary surgeons. The optimal technique should enable secure sealing of the vascular and biliary structures that results in low intraoperative blood loss as well as low postoperative complication rates. Although numerous devices have been introduced and are used widely, high-level evidence, randomized controlled trials, that evaluate efficacy and safety of these devices are scarce. In the present randomized controlled trial two techniques of hepatic resection using vascular staplers and the LigaSure vessel sealing device are compared. While the primary endpoint is intraoperative blood loss a set of general and surgical variables will be analyzed to evaluate efficacy and safety of both methods.

Conditions

Interventions

TypeNameDescription
PROCEDUREStapler hepatectomyLiver resection using vascular stapler for transection of the parenchyma
PROCEDURELigaSure hepatectomyLiver resection using LigaSure for transection of the parenchyma
DEVICELigasure
OTHERvascular staple

Timeline

Start date
2011-11-02
Primary completion
2014-07-17
Completion
2014-08-14
First posted
2013-05-21
Last updated
2017-10-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01858987. Inclusion in this directory is not an endorsement.